tetrahydrocannabivarin 9 has been researched along with dronabinol in 32 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (6.25) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 8 (25.00) | 29.6817 |
| 2010's | 22 (68.75) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Braut-Boucher, F; Fournier, E; Hoellinger, H; Paris, M | 1 |
| Rigor, BM; Schurr, A | 1 |
| ElSohly, MA; Feng, S; Fortner, N; Mehmedic, Z; Murphy, TP; Nimrod, A; Ross, S; Warrington, AW | 1 |
| deWit, H; ElSohly, MA; Feng, S; Murphy, TP; Wachtel, SR | 1 |
| Baillie, G; Pertwee, RG; Price, MR; Ross, RA; Stevenson, LA; Thomas, A; Wease, KN | 1 |
| Lichtman, AH; Martin, BR; Pertwee, RG; Razdan, RK; Ross, RA; Stevenson, LA; Thomas, A; Varvel, SA | 1 |
| Pertwee, RG | 1 |
| Ma, YL; Stephens, GJ; Weston, SE; Whalley, BJ | 1 |
| Dennis, I; Stephens, GJ; Whalley, BJ | 1 |
| Fadda, P; McKillop-Smith, S; Pertwee, RG; Platt, B; Riedel, G; Robinson, L | 1 |
| Bevan, SA; Hill, AJ; Jones, NA; Smith, I; Stephens, GJ; Weston, SE; Whalley, BJ; Williams, CM; Williamson, EM | 1 |
| Bolognini, D; Cascio, MG; Comelli, F; Costa, B; Di Marzo, V; Gauson, LA; Maione, S; Marini, P; Parolaro, D; Pertwee, RG; Ross, RA | 1 |
| Bolognini, D; Cascio, MG; Parolaro, D; Pertwee, RG | 1 |
| Raffa, RB; Ward, SJ | 1 |
| Amada, N; Arthur, M; Close, S; Deiana, S; Dorward, P; Fleming, S; Pigliacampo, B; Platt, B; Riedel, G; Watanabe, A; Woodcock, H; Yamasaki, Y | 1 |
| Dashney, B; Limebeer, CL; O'Brien, LD; Parker, LA; Rock, EM; Segsworth, B; Wills, KL | 1 |
| Duncan, M; Parker, LA; Rock, EM; Sticht, MA; Stott, C | 1 |
| Dar, MS | 1 |
| Di Marzo, V; Duncan, M; McPartland, JM; Pertwee, RG | 1 |
| Cascio, MG; Marini, P; Parolaro, D; Pertwee, RG; Zamberletti, E | 1 |
| Cowen, PJ; McCabe, C; Tudge, L; Williams, C | 1 |
| Cawthorne, M; Di Marzo, V; Guadagnino, I; Martella, A; Melck, D; Motta, A; Paris, D; Silvestri, C | 1 |
| McCabe, C; Rzepa, E; Tudge, L | 1 |
| Atakan, Z; Englund, A; Kralj, A; Morrison, P; Murray, R; Tunstall, N | 1 |
| Barnes, AJ; Huestis, MA; Newmeyer, MN; Scheidweiler, KB | 1 |
| Borrelli, F; Capasso, R; Cascio, MG; Izzo, AA; Marzo, VD; Orlando, P; Pagano, E; Pertwee, R; Romano, B | 1 |
| Barrett, DA; Bell, JD; Jadoon, KA; O'Sullivan, SE; Ratcliffe, SH; Stott, C; Tan, GD; Thomas, EL | 1 |
| Friedman, D; Gaston, TE | 1 |
| Di Marzo, V; Izzo, AA; Lauritano, A; Pagano, E; Piscitelli, F | 1 |
| Nutt, D | 1 |
| Cho, AE; Jung, SW; Yu, W | 1 |
| Greenway, FL; Kirwan, JP | 1 |
4 review(s) available for tetrahydrocannabivarin 9 and dronabinol
| Article | Year |
|---|---|
The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: delta9-tetrahydrocannabinol, cannabidiol and delta9-tetrahydrocannabivarin.
Topics: Animals; Cannabidiol; Dronabinol; Drug Tolerance; Humans; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Synaptic Transmission | 2008 |
CB₁-independent mechanisms of Δ⁹-THCV, AM251 and SR141716 (rimonabant).
Topics: Animals; Anti-Obesity Agents; Appetite Depressants; Dronabinol; Humans; Ligands; Piperidines; Pyrazoles; Receptor, Cannabinoid, CB1; Receptors, Opioid, mu; Rimonabant | 2012 |
Are cannabidiol and Δ(9) -tetrahydrocannabivarin negative modulators of the endocannabinoid system? A systematic review.
Topics: Animals; Cannabidiol; Cannabinoid Receptor Modulators; Dronabinol; Endocannabinoids; Humans; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2 | 2015 |
Pharmacology of cannabinoids in the treatment of epilepsy.
Topics: Animals; Anticonvulsants; Cannabidiol; Cannabinoids; Cannabis; Dronabinol; Drug Combinations; Epilepsy; Humans; Receptor, Cannabinoid, CB1; Treatment Outcome | 2017 |
5 trial(s) available for tetrahydrocannabivarin 9 and dronabinol
| Article | Year |
|---|---|
Delta9-tetrahydrocannabivarin as a marker for the ingestion of marijuana versus Marinol: results of a clinical study.
Topics: Administration, Oral; Adult; Biomarkers; Cross-Over Studies; Dronabinol; Female; Gas Chromatography-Mass Spectrometry; Hallucinogens; Humans; Liver; Male; Marijuana Smoking; Sensitivity and Specificity; Substance Abuse Detection | 2001 |
Neural effects of cannabinoid CB1 neutral antagonist tetrahydrocannabivarin on food reward and aversion in healthy volunteers.
Topics: Adult; Affect; Anti-Obesity Agents; Avoidance Learning; Brain; Brain Mapping; Cacao; Cannabinoid Receptor Antagonists; Cross-Over Studies; Double-Blind Method; Dronabinol; Feeding Behavior; Female; Fragaria; Fruit; Fungi; Healthy Volunteers; Humans; Magnetic Resonance Imaging; Male; Photic Stimulation; Receptor, Cannabinoid, CB1; Reward; Taste; Taste Perception; Visual Perception; Young Adult | 2014 |
The CB1 Neutral Antagonist Tetrahydrocannabivarin Reduces Default Mode Network and Increases Executive Control Network Resting State Functional Connectivity in Healthy Volunteers.
Topics: Adult; Brain; Cross-Over Studies; Double-Blind Method; Dronabinol; Executive Function; Female; Healthy Volunteers; Humans; Magnetic Resonance Imaging; Male; Nerve Net; Receptor, Cannabinoid, CB1; Rest; Young Adult | 2015 |
The effect of five day dosing with THCV on THC-induced cognitive, psychological and physiological effects in healthy male human volunteers: A placebo-controlled, double-blind, crossover pilot trial.
Topics: Adult; Cognition; Cross-Over Studies; Double-Blind Method; Dronabinol; Hallucinogens; Heart Rate; Humans; Male; Memory; Mental Recall; Pilot Projects; Young Adult | 2016 |
Efficacy and Safety of Cannabidiol and Tetrahydrocannabivarin on Glycemic and Lipid Parameters in Patients With Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Pilot Study.
Topics: Aged; Blood Glucose; Body Mass Index; Body Weight; Cannabidiol; Cholesterol; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Double-Blind Method; Dronabinol; Endpoint Determination; Female; Gastric Inhibitory Polypeptide; Glycated Hemoglobin; Humans; Male; Middle Aged; Pilot Projects; Triglycerides | 2016 |
23 other study(ies) available for tetrahydrocannabivarin 9 and dronabinol
| Article | Year |
|---|---|
Isolation and toxicological study of tetrahydrocannabivarol, an homolog of tetrahydrocannabinol (delta 1--THC).
Topics: Animals; Cannabis; Chemical Phenomena; Chemistry; Dronabinol; Drug Hypersensitivity; Guinea Pigs; Isomerism; Magnetic Resonance Spectroscopy; Mass Spectrometry | 1979 |
Cannabis extract, but not delta 1-tetrahydrocannabinol, inhibits human brain and liver monoamine oxidase.
Topics: Brain; Cannabinoids; Cannabis; Chromatography, Thin Layer; Dronabinol; Humans; Mitochondria, Liver; Monoamine Oxidase Inhibitors; Plant Extracts; Substrate Specificity | 1984 |
Identification and quantitation of 11-nor-delta9-tetrahydrocannabivarin-9-carboxylic acid, a major metabolite of delta9-tetrahydrocannabivarin.
Topics: Chromatography, High Pressure Liquid; Dronabinol; Gas Chromatography-Mass Spectrometry; Hallucinogens; Humans; Marijuana Abuse; Urinalysis | 2001 |
Evidence that the plant cannabinoid Delta9-tetrahydrocannabivarin is a cannabinoid CB1 and CB2 receptor antagonist.
Topics: Animals; Arachidonic Acids; Benzoxazines; Cannabinoids; Cannabis; CHO Cells; Clonidine; Cricetinae; Dose-Response Relationship, Drug; Dronabinol; Endocannabinoids; Guanosine 5'-O-(3-Thiotriphosphate); In Vitro Techniques; Male; Mice; Morpholines; Muscle Contraction; Naphthalenes; Polyunsaturated Alkamides; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Vas Deferens | 2005 |
The psychoactive plant cannabinoid, Delta9-tetrahydrocannabinol, is antagonized by Delta8- and Delta9-tetrahydrocannabivarin in mice in vivo.
Topics: Analgesics, Non-Narcotic; Animals; Benzoxazines; Binding, Competitive; Body Temperature; Brain; Cannabinoid Receptor Agonists; Cannabinoid Receptor Antagonists; Cyclohexanes; Cyclohexanols; Dose-Response Relationship, Drug; Dronabinol; Electric Stimulation; Guanosine 5'-O-(3-Thiotriphosphate); In Vitro Techniques; Locomotion; Male; Mice; Mice, Inbred ICR; Morpholines; Muscle Contraction; Muscle, Smooth; Naphthalenes; Pain Measurement; Pain Threshold; Phenols; Protein Binding; Psychotropic Drugs; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Receptors, Cannabinoid; Vas Deferens | 2007 |
The phytocannabinoid Delta(9)-tetrahydrocannabivarin modulates inhibitory neurotransmission in the cerebellum.
Topics: Animals; Benzoxazines; Bicuculline; Cannabinoids; Cerebellum; Dronabinol; Electrophysiology; Excitatory Postsynaptic Potentials; GABA Antagonists; gamma-Aminobutyric Acid; In Vitro Techniques; Male; Mice; Morpholines; Naphthalenes; Patch-Clamp Techniques; Piperidines; Purkinje Cells; Pyrazoles; Receptor, Cannabinoid, CB1; Rimonabant; Synapses; Synaptic Transmission | 2008 |
Effects of Delta9-tetrahydrocannabivarin on [35S]GTPgammaS binding in mouse brain cerebellum and piriform cortex membranes.
Topics: Animals; Benzoxazines; Cannabinoids; Cerebellum; Data Interpretation, Statistical; Dronabinol; Electrophysiology; GTP-Binding Proteins; Guanosine 5'-O-(3-Thiotriphosphate); In Vitro Techniques; Kinetics; Membranes; Mice; Morpholines; Naphthalenes; Olfactory Pathways; Piperidines; Pyrazoles; Receptor, Cannabinoid, CB1 | 2008 |
Synthetic and plant-derived cannabinoid receptor antagonists show hypophagic properties in fasted and non-fasted mice.
Topics: Animals; Appetite Depressants; Cannabinoid Receptor Antagonists; Dronabinol; Eating; Fasting; Feeding Behavior; Male; Mice; Mice, Inbred C57BL; Piperidines; Pyrazoles; Solvents; Weight Gain | 2009 |
Δ⁹-Tetrahydrocannabivarin suppresses in vitro epileptiform and in vivo seizure activity in adult rats.
Topics: Animals; Cerebral Cortex; Competitive Bidding; Disease Models, Animal; Dronabinol; Drug Interactions; Epilepsy; Evoked Potentials; Female; Guanosine 5'-O-(3-Thiotriphosphate); In Vitro Techniques; Male; Pentylenetetrazole; Phosphorus Isotopes; Piperidines; Pyrazoles; Rats; Receptor, Cannabinoid, CB1; Rimonabant | 2010 |
The plant cannabinoid Delta9-tetrahydrocannabivarin can decrease signs of inflammation and inflammatory pain in mice.
Topics: Animals; Cell Line, Transformed; CHO Cells; Cricetinae; Cricetulus; Cyclic AMP; Dose-Response Relationship, Drug; Dronabinol; Edema; Guanosine 5'-O-(3-Thiotriphosphate); Humans; Inflammation; Male; Membranes; Mice; Mice, Inbred C57BL; Pain; Pain Measurement; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Spleen | 2010 |
AM630 behaves as a protean ligand at the human cannabinoid CB2 receptor.
Topics: Animals; Benzoxazines; Camphanes; Cannabinoids; CHO Cells; Cricetinae; Cricetulus; Cyclohexanols; Dronabinol; Humans; Indoles; Ligands; Morpholines; Naphthalenes; Pyrazoles; Radioligand Assay; Receptor, Cannabinoid, CB2 | 2012 |
Plasma and brain pharmacokinetic profile of cannabidiol (CBD), cannabidivarine (CBDV), Δ⁹-tetrahydrocannabivarin (THCV) and cannabigerol (CBG) in rats and mice following oral and intraperitoneal administration and CBD action on obsessive-compulsive behavi
Topics: Administration, Oral; Animals; Cannabidiol; Cannabinoids; Compulsive Behavior; Dronabinol; Injections, Intraperitoneal; Male; Mice; Obsessive Behavior; Rats; Rats, Wistar | 2012 |
Effect of chronic exposure to rimonabant and phytocannabinoids on anxiety-like behavior and saccharin palatability.
Topics: Animals; Anxiety; Behavior, Animal; Cannabidiol; Cannabinoid Receptor Antagonists; Cannabinoids; Disease Models, Animal; Dronabinol; Drug Administration Schedule; Drug Inverse Agonism; Male; Piperidines; Pyrazoles; Rats; Rats, Sprague-Dawley; Rimonabant; Saccharin; Taste; Taste Perception | 2013 |
Evaluation of the potential of the phytocannabinoids, cannabidivarin (CBDV) and Δ(9) -tetrahydrocannabivarin (THCV), to produce CB1 receptor inverse agonism symptoms of nausea in rats.
Topics: Animals; Behavior, Animal; Cannabinoid Receptor Agonists; Cannabinoids; Disease Models, Animal; Dronabinol; Drug Partial Agonism; Lithium Chloride; Male; Nausea; Phytochemicals; Piperidines; Pyrazoles; Rats; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB1; Rimonabant | 2013 |
Functional interaction and cross-tolerance between ethanol and Δ9-THC: possible modulation by mouse cerebellar adenosinergic A1/GABAergic-A receptors.
Topics: Adenosine; Animals; Cannabinoid Receptor Agonists; Central Nervous System Depressants; Cerebellar Ataxia; Cerebellum; Dronabinol; Drug Interactions; Drug Tolerance; Ethanol; GABA-A Receptor Agonists; Male; Mice; Mice, Inbred Strains; Microinjections; Muscimol; Purinergic P1 Receptor Agonists; Receptor, Adenosine A1; Receptors, GABA-A | 2014 |
The phytocannabinoid, Δ⁹-tetrahydrocannabivarin, can act through 5-HT₁A receptors to produce antipsychotic effects.
Topics: Animals; Antipsychotic Agents; Cannabinoids; CHO Cells; Cricetulus; Dronabinol; Male; Molecular Sequence Data; Molecular Structure; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT1A; Schizophrenia; Schizophrenic Psychology | 2015 |
Two non-psychoactive cannabinoids reduce intracellular lipid levels and inhibit hepatosteatosis.
Topics: 3T3-L1 Cells; Adipocytes; Animals; Cannabidiol; Cannabinoids; Cell Line; Dronabinol; Hepatocytes; Humans; Lipid Metabolism; Mice; Mice, Obese; Non-alcoholic Fatty Liver Disease; Oleic Acid; Receptor, Cannabinoid, CB1; Triglycerides; TRPV Cation Channels; Zebrafish | 2015 |
Quantification of cannabinoids and their free and glucuronide metabolites in whole blood by disposable pipette extraction and liquid chromatography-tandem mass spectrometry.
Topics: Biomarkers; Cannabidiol; Cannabinoids; Chromatography, Liquid; Dronabinol; Glucuronides; Humans; Marijuana Smoking; Substance Abuse Detection; Tandem Mass Spectrometry | 2016 |
Pure Δ
Topics: Animals; Cannabinoids; Cannabis; Cell Line; CHO Cells; Cricetulus; Cyclooxygenase 2; Dronabinol; Lipopolysaccharides; Macrophages, Peritoneal; Male; Mice; Mice, Inbred ICR; Nitric Oxide; Nitric Oxide Synthase Type II; Nitrites; Plant Extracts; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; RNA, Messenger; Transient Receptor Potential Channels; Up-Regulation | 2016 |
Development of a Rapid LC-MS/MS Method for the Quantification of Cannabidiol, Cannabidivarin, Δ
Topics: Animals; Cannabidiol; Cannabinoids; Chromatography, High Pressure Liquid; Colitis; Colon; Dronabinol; Limit of Detection; Male; Mice; Mice, Inbred ICR; Pancreas; Tandem Mass Spectrometry | 2017 |
New ACMD regulations threaten UK's pharmaceutical discovery.
Topics: Advisory Committees; Biomedical Research; Dronabinol; Drug Discovery; Government Regulation; United Kingdom | 2017 |
Exploring the Ligand Efficacy of Cannabinoid Receptor 1 (CB1) using Molecular Dynamics Simulations.
Topics: Cannabinoid Receptor Agonists; Cannabinoid Receptor Antagonists; Cannabinoids; Dronabinol; Drug Design; Ligands; Molecular Docking Simulation; Molecular Dynamics Simulation; Protein Binding; Protein Conformation; Receptor, Cannabinoid, CB1 | 2018 |
Medical marijuana-an obesity problem or opportunity?
Topics: Appetite Stimulants; Dronabinol; Humans; Medical Marijuana; Obesity | 2019 |